Henry Schein, Inc. (NASDAQ:HSIC) – Stock analysts at William Blair decreased their Q3 2017 EPS estimates for shares of Henry Schein in a report released on Sunday. William Blair analyst J. Kreger now anticipates that the company will earn $0.87 per share for the quarter, down from their prior forecast of $0.88. William Blair also issued estimates for Henry Schein’s FY2017 earnings at $3.61 EPS and FY2020 earnings at $4.93 EPS.
A number of other research firms have also recently commented on HSIC. Zacks Investment Research cut shares of Henry Schein from a “buy” rating to a “hold” rating in a research note on Wednesday, August 9th. Northcoast Research raised shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $109.00 target price for the company in a research note on Monday, August 7th. Robert W. Baird set a $95.00 target price on shares of Henry Schein and gave the stock a “buy” rating in a research note on Thursday, October 19th. UBS AG reissued a “buy” rating on shares of Henry Schein in a research note on Friday, September 15th. Finally, Piper Jaffray Companies raised shares of Henry Schein from a “neutral” rating to an “overweight” rating in a research note on Friday, September 15th. One analyst has rated the stock with a sell rating, eleven have issued a hold rating and six have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $92.89.
COPYRIGHT VIOLATION NOTICE: “Q3 2017 EPS Estimates for Henry Schein, Inc. (HSIC) Decreased by William Blair” was reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.com-unik.info/2017/11/03/q3-2017-eps-estimates-for-henry-schein-inc-hsic-decreased-by-william-blair.html. Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, August 8th. The company reported $0.88 EPS for the quarter, beating the consensus estimate of $0.86 by $0.02. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The business had revenue of $3.06 billion during the quarter, compared to the consensus estimate of $3.05 billion. During the same quarter in the prior year, the firm earned $0.82 EPS. The business’s revenue was up 6.4% on a year-over-year basis.
Henry Schein declared that its Board of Directors has approved a stock repurchase program on Monday, September 18th that authorizes the company to repurchase $400.00 million in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 6.3% of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s board believes its stock is undervalued.
In related news, SVP Paul Rose sold 2,126 shares of the company’s stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $172.51, for a total transaction of $366,756.26. Following the completion of the sale, the senior vice president now owns 17,841 shares of the company’s stock, valued at approximately $3,077,750.91. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 1.19% of the stock is currently owned by corporate insiders.
A number of large investors have recently bought and sold shares of HSIC. Vanguard Group Inc. lifted its holdings in shares of Henry Schein by 3.0% in the 2nd quarter. Vanguard Group Inc. now owns 8,086,317 shares of the company’s stock worth $1,479,959,000 after acquiring an additional 236,862 shares during the last quarter. FMR LLC lifted its holdings in shares of Henry Schein by 0.4% in the 2nd quarter. FMR LLC now owns 6,921,367 shares of the company’s stock worth $1,266,749,000 after acquiring an additional 24,935 shares during the last quarter. BlackRock Inc. lifted its holdings in shares of Henry Schein by 1.8% in the 2nd quarter. BlackRock Inc. now owns 5,696,685 shares of the company’s stock worth $1,042,607,000 after acquiring an additional 101,406 shares during the last quarter. Alecta Pensionsforsakring Omsesidigt lifted its holdings in shares of Henry Schein by 112.0% in the 3rd quarter. Alecta Pensionsforsakring Omsesidigt now owns 5,313,980 shares of the company’s stock worth $435,693,000 after acquiring an additional 2,806,990 shares during the last quarter. Finally, Swedbank lifted its holdings in shares of Henry Schein by 84.9% in the 3rd quarter. Swedbank now owns 2,358,594 shares of the company’s stock worth $193,381,000 after acquiring an additional 1,083,115 shares during the last quarter. Institutional investors own 47.48% of the company’s stock.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
What are top analysts saying about Henry Schein Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Henry Schein Inc. and related companies.